Adult patients with metabolic dysfunction–associated steatohepatitis (MASH) and moderate or advanced liver fibrosis showed improved liver histology with a once-weekly dose of semaglutide (Wegovy ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

But when too much fat builds up in the liver over time, it can lead to a condition called metabolic dysfunction-associated steatohepatitis, better known as MASH. This condition is most common in ...

Madrigal Pharma has become the first drugmaker to claim FDA approval for a drug to treat metabolic dysfunction-associated steatohepatitis (MASH), an elusive target that has seen many other ...

A filmic companion to the Weeknd’s latest album, this meta psychological thriller is all style and no substance. By Brandon Yu A housewife’s domestic distresses take a horrifying turn in this ...